Pirker W - Search Results

1

Role of LINGO1 polymorphisms in Parkinson's disease.

Haubenberger D, Hotzy C, Pirker W, Katzenschlager R, Brücke T, Zimprich F, Auff E, Zimprich A. Haubenberger D, et al. Among authors: pirker w. Mov Disord. 2009 Dec 15;24(16):2404-7. doi: 10.1002/mds.22768. Mov Disord. 2009. PMID: 19908305 Free PMC article.

2

Iodine-123-IBZM-SPECT: studies in 15 patients with pituitary tumors.

Pirker W, Brücke T, Riedl M, Clodi M, Luger A, Asenbaum S, Podreka I, Deecke L. Pirker W, et al. J Neural Transm Gen Sect. 1994;97(3):235-44. doi: 10.1007/BF02336144. J Neural Transm Gen Sect. 1994. PMID: 7873131 Clinical Trial.

3

beta-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo.

Pirker W, Asenbaum S, Kasper S, Walter H, Angelberger P, Koch G, Pozzera A, Deecke L, Podreka I, Brücke T. Pirker W, et al. J Neural Transm Gen Sect. 1995;100(3):247-56. doi: 10.1007/BF01276462. J Neural Transm Gen Sect. 1995. PMID: 8748670

4

Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.

Pirker W, Riedl M, Luger A, Czech T, Rössler K, Asenbaum S, Angelberger P, Kornhuber J, Deecke L, Podreka I, Brücke T. Pirker W, et al. J Nucl Med. 1996 Dec;37(12):1931-7. J Nucl Med. 1996. PMID: 8970508 Free article.

5

Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.

Asenbaum S, Brücke T, Pirker W, Podreka I, Angelberger P, Wenger S, Wöber C, Müller C, Deecke L. Asenbaum S, et al. Among authors: pirker w. J Nucl Med. 1997 Jan;38(1):1-6. J Nucl Med. 1997. PMID: 8998140 Free article.

6

Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.

Brücke T, Asenbaum S, Pirker W, Djamshidian S, Wenger S, Wöber C, Müller C, Podreka I. Brücke T, et al. Among authors: pirker w. J Neural Transm Suppl. 1997;50:9-24. J Neural Transm Suppl. 1997. PMID: 9120429

7

[123I]beta-CIT single-photon emission tomography in DOPA-responsive dystonia.

Naumann M, Pirker W, Reiners K, Lange K, Becker G, Brücke T. Naumann M, et al. Among authors: pirker w. Mov Disord. 1997 May;12(3):448-51. doi: 10.1002/mds.870120330. Mov Disord. 1997. PMID: 9159746

8

Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease.

Pirker W, Asenbaum S, Wenger S, Kornhuber J, Angelberger P, Deecke L, Podreka I, Brücke T. Pirker W, et al. J Nucl Med. 1997 Nov;38(11):1711-7. J Nucl Med. 1997. PMID: 9374338 Free article.

9

Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT.

Naumann M, Pirker W, Reiners K, Lange KW, Becker G, Brücke T. Naumann M, et al. Among authors: pirker w. Mov Disord. 1998 Mar;13(2):319-23. doi: 10.1002/mds.870130219. Mov Disord. 1998. PMID: 9539347

10

Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison.

Asenbaum S, Brücke T, Pirker W, Pietrzyk U, Podreka I. Asenbaum S, et al. Among authors: pirker w. J Nucl Med. 1998 Apr;39(4):613-8. J Nucl Med. 1998. PMID: 9544665 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters